Lexaria Bioscience Corp.

LEXX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.42

+$0.18 (+5.56%)

At close: Sep 21, 2026, 4:00 PM ET

$3.42

$0 (+0.15%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Aug 30, 2025	FY 2024 Aug 30, 2024	FY 2023 Aug 30, 2023	FY 2022 Aug 30, 2022	FY 2021 Aug 30, 2021	FY 2020 Aug 30, 2020
Revenue	705.92K	464.28K	226.21K	255.4K	722.74K	384.54K
Cost of Revenue	2.72K	4.82K	31.5K	71.84K	175.35K	99.38K
Gross Profit	703.2K	459.46K	194.71K	183.56K	547.39K	215.42K
Operating Income	-11.88M	-5.75M	-6.53M	-6.62M	-5.69M	-4.15M
Interest Income	3.02K	14.31K	43.19K	n/a	n/a	n/a
Pretax Income	-11.91M	-5.81M	-6.71M	-7.38M	-4.16M	-4.15M
Net Income	-11.9M	-5.8M	-6.66M	-7.27M	-4.03M	-3.93M
Selling & General & Admin	4.35M	3.85M	3.06M	4.96M	4.97M	3.98M
Research & Development	8.24M	2.36M	3.67M	1.84M	1.26M	387.07K
Other Expenses	n/a	n/a	n/a	n/a	n/a	69.75K
Operating Expenses	12.58M	6.21M	6.73M	6.8M	6.23M	4.43M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.59M	6.22M	6.76M	6.87M	6.41M	4.53M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	1.2M	825.6K	440.94K	392.35K	292.76K	184.89K
Shares Outstanding (Diluted)	1.2M	825.6K	440.94K	392.35K	292.76K	184.89K
EPS (Basic)	-9.90	-7.05	-15.15	-18.60	-13.80	-21.30
EPS (Diluted)	-9.90	-7.05	-15.15	-18.60	-13.80	-21.30
EBITDA	-11.82M	-5.73M	-6.57M	-7.28M	-4.02M	-4M
EBIT	-11.91M	-5.81M	-6.71M	-7.38M	-4.16M	-4.15M
Depreciation & Amortization	87.83K	76.15K	145.4K	102.72K	147.6K	146.09K